There are 360 resources available
243P - Skin biopsies for pharmacodynamic studies of tebentafusp, a novel bispecific molecule against the melanocytic antigen gp100.
Presenter: Ramon Stäger
Session: Poster Display
244P - DNA-PK inhibition sustains immune activation in SCLC
Presenter: Carminia Maria Della Corte
Session: Poster Display
Welcome and introductions
Presenter: Vincenzo Bronte
Session: Bristol Myers Squibb - Exploring new advancements in chemokine signaling in tumor biology: Focus on IL-8, CXCR1, and CXCR2
Resources:
Webcast
Spotlight on I-O: Chemokine signaling and its role in tumor development and I-O resistance
Presenter: Vincenzo Bronte
Session: Bristol Myers Squibb - Exploring new advancements in chemokine signaling in tumor biology: Focus on IL-8, CXCR1, and CXCR2
Resources:
Webcast
Caught in a NET: Reviewing IL-8, CXCR1, and CXCR2 signaling in tumor biology
Presenter: Ignacio Melero
Session: Bristol Myers Squibb - Exploring new advancements in chemokine signaling in tumor biology: Focus on IL-8, CXCR1, and CXCR2
Resources:
Webcast
Emerging data for targeting IL-8, CXCR1, and/or CXCR2 as potential treatment options in solid tumors
Presenter: Matteo Simonelli
Session: Bristol Myers Squibb - Exploring new advancements in chemokine signaling in tumor biology: Focus on IL-8, CXCR1, and CXCR2
Resources:
Webcast
Closing remarks and audience Q&A
Presenter: Vincenzo Bronte
Session: Bristol Myers Squibb - Exploring new advancements in chemokine signaling in tumor biology: Focus on IL-8, CXCR1, and CXCR2
Resources:
Webcast
2MO - First-line (1L) nivolumab (NIVO) + ipilimumab (IPI) in metastatic non-small cell lung cancer (mNSCLC): clinical outcomes and biomarker analyses from CheckMate 592
Presenter: Michael Schenker
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast
3MO - Comprehensive biomarkers (BMs) analysis to predict efficacy of PD1/L1 immune checkpoint inhibitors (ICIs) in combination with chemotherapy: a subgroup analysis of the Precision Immuno-Oncology for advanced Non-Small CEll Lung CancER (PIONeeR) trial
Presenter: Fabrice Barlesi
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast
Introduction and first vote
Presenter: Jean-Pascal Machiels
Session: Combination of radiotherapy and immunotherapy is a good idea
Resources:
Slides
Webcast